Mammary gland neoplasia in long-term rodent studies

Environmental Health Perspectives

Volumn 104, Issue 9, 1996, Pages 938-967

  Russo, Irma H ^a,b   Russo, Jose ^a  

^a League Women Against Cancer L   (United States)

^b LOWAC Corp   (United States)

Author keywords

Breast cancer; Chemically induced mammary carcinogenesis; Endocrine system; Hormones; Rodent mammary gland; Rodent tumor model

Indexed keywords

7,12 DIMETHYLBENZ[A]ANTHRACENE; ENVIRONMENTAL CHEMICAL; HORMONE; METHYLNITROSOUREA;

ANAMNESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; BREAST CANCER; BREAST CARCINOGENESIS; DIET; DISEASE PREDISPOSITION; DOSE RESPONSE; ENDOCRINE SYSTEM; HEREDITY; IONIZING RADIATION; LATENT PERIOD; NONHUMAN; PRIORITY JOURNAL; RADIATION EXPOSURE; REVIEW; RISK ASSESSMENT; SOCIAL STATUS;

ANIMALIA; RODENTIA;

EID: 0029844233     PISSN: 00916765     EISSN: None     Source Type: Journal    
DOI: 10.1289/ehp.96104938     Document Type: Review

References (266)

1. Dorland's illustrated medical dictionary. 25th ed. Philadelphia, PA:W.B. Saunders, 1974.
2. Rubin E, Farber JL, eds. Pathology. Philadelphia:J.B. Lippincott, 1994.
3. American Cancer Society. Selected cancers. Cancer facts and figures, 1994. Atlanta, GA:American Cancer Society, 1994;9-17.
4. Wingo PA, Tong T, Bolden S. Cancer Statistics, 1995. Ca Cancer J Clin 45:8-30 (1995).
5. Kelsey JL, Horn-Ross PL. Breast cancer: magnitude of the problem and descriptive epidemiology. Epidemiol Rev 15:7-16 (1993).
6. Steele GD Jr, Osteen RT, Winchester DP, Murphy GP, Menck HR. Clinical highlights from the National Cancer Data Base: 1994. Ca Cancer J Clin 44:71-78 (1994).
7. Anderson EL. Cancer risk assessments: an overview. In: Oncogene and transgenics correlates of cancer risk assessments. (Zervos C, ed). New York:Plenum Press, 1992;1-20.
8. Finch C. Reproductive senescence in rodents: factors in the decline of fertility and loss of regular estrous cycles. In: The aging reproductive system (Schneyder E, ed). New York:Raven Press, 1978; 193-212.
9. Welsch CW. Rodent models to examine in vivo hormonal regulation of mammary gland tumorigenesis. In: Cellular and molecular biology of mammary cancer (Medina D, Kidwell W, Heppner G, Anderson E, eds). New York:Plenum Press, 1987:163-179.
10. Callahan R. Retrovirus and proto-oncogene involvement in the etiology of breast neoplasia. In: The mammary gland (Neville MC, Daniel CW, eds). New York:Plenum Press, 1987; 323-351.
11. Teich N, Wyke J, Mak T, Bernstein A, Hardy W. Pathogenesis of retrovirus-induced disease. In: RNA tumor viruses, (Weiss R, Teich N, Varmus H, Coffin J, eds). Cold Spring Harbor, NY:Cold Spring Harbor Laboratory, 1982;785-998.
12. Grubbs CJ, Farnell DR, Hill DL, McDonough KC. Chemoprevention of N-nitroso-N-methylurea-induced mammary cancers by pretreatment wich 17β-estradiol and progesterone. J Natl Cancer Inst 4:927-932 (1985).
13. Grubbs CJ, Hill DL, McDonough KC, Peckham JC. N-nitroso-N-methylurea-induced mammary carcinogenesis: effect of pregnancy in preneoplastic cells. J Natl Cancer Inst 71:625-628 (1983).
14. Grubbs CJ, Juliana MM, Hill DL, Whitaker LM. Suppression by pregnancy of chemically induced preneoplastic cells of the rat mammary gland. Anticancer Res 6:2395-2401 (1986).
15. Russo J, Saby J, Isenberg W, Russo IH. Pathogenesis of mammary carcinoma induced in rats by 7,12-dimethylbenz(a)anthracene. J Natl Cancer Inst 59:435-445 (1977).
16. Russo IH, Russo J. Developmental stage of the rat mammary gland as determinant of its susceptibility to 7,12-dimethylbenz(a)anthracene. J Natl Cancer Inst 61:1439-1449 (1978).
17. Russo J, Russo IH. DNA labeling index and structure of the rat mammary gland as determinant of its susceptibility to carcinogenesis. J Natl Cancer Inst 61:1451-1459 (1978).
18. Russo J, Wilgus G, Russo IH. Susceptibility of the mammary gland to carcinogenesis. I. Differentiation of the mammary gland as determinant of tumor incidence and type of lesion. Am J Pathol 96:721-736 (1979).
19. Russo J, Russo IH. Influence of differentiation and cell kinetics on the susceptibility of the rat mammary gland to carcinogenesis. Cancer Res 40:2677-2687 (1980).
20. Russo J, Russo IH. Susceptibility of the mammary gland to carcinogenesis. II. Pregnancy interruption as a risk factor in tumor incidence. Am J Pathol 100:497-512 (1980).
21. Russo J, Tay LK, Russo IH. Model systems to study breast carcinogenesis. In: Laboratory medicine. Advances in Pathology, vol 2 (Levy E, ed). Oxford:Pergamon Press, 1981;27-30.
22. Russo J, Tay LK, Russo IH. Differentiation of the mammary gland and susceptibility to carcinogenesis. Breast Cancer Res Treat 2:5-37 (1982).
23. Russo J, Gusterson BA, Rogers AE, Russo IH, Wellings SR, Van Zwieten MJ. Comparative study of human and rat mammary tumorigenesis. Lab Invest 62:1-32 (1990).
24. Russo J, Russo IH, van Zwieten MJ, Rogers AE, Gusterson B. Classification of neoplastic and non-neoplastic lesions of the rat mammary gland. In: Integument and mammary glands of laboratory animals (Jones TC, Mohr U, Hunt RD, eds). Berlin:Springer-Verlag, 1989; 275-304.
25. Huggins C. Two principles in endocrine therapy of cancers; hormone deprival and hormone interference. Cancer Res 25:1163-1167 (1965).
26. Huggins C, Grand LC, Brillantes FP. Critical significance of breast structure in the induction of mammary cancer in the rat. Proc Natl Acad Sci USA 45:1294-1300 (1959).
27. Huggins C, Lorraine C, Grand LC, Brillantes FP. Mammary cancer induced by a single feeding of polynuclear hydrocarbons and its suppression. Nature 189:204-207 (1961).
28. Huggins C, Moon RC, Moni S. Extinction of experimental mammary cancer. I. Estradiol-17β and progesterone. Proc Natl Acad Sci USA 48:379-386 (1962).
29. Huggins C, Yang NC. Induction and extinction of mammary cancer. Science 137:257-262 (1962).
30. McCormick DL, Moon RC. Retinoid-tamoxifen interaction in mammary cancer chemoprevention. Carcinogenesis 7:193-196 (1986).
31. McCormick DL. Anticarcinogenic activity of quinacrine in the rat mammary gland. Carcinogenesis 9:175-178 (1988).
32. McCormick DL, Adamowski CB, Fiks A, Moon RC. Lifetime dose-response relationships for mammary tumor reduction by a single administration of N-methyl-N-nitrosourea. Cancer Res 41:1690-1694 (1981).
33. McCormick DL, Burns FJ, Albert RE. Inhibition of benzo(a)pyrene-induced mammary Carcinogenesis by retinyl acetate. J Natl Cancer Inst 66:559-564 (1981).
34. McCormick DL, Mehta RG, Thompson CA, Dinger N, Caldwell JA, Moon RC. Enhanced inhibition of mammary Carcinogenesis by combined treatment with n-(4-hydroxyphenyl) retinamide and ovariectomy. Cancer Res 42:508-512 (1982).
35. Moon RC, McCormick DL, Mehta RG. Inhibition of Carcinogenesis by retinoids. Cancer Res(suppl) 43:2469s-2475s (1983).
36. Medina D, Shepherd F. Selenium-mediated inhibition of 7,12-dimethylbenz(a)anthracene induced mouse mammary tumorigenesis. Carcinogenesis 2:451-455 (1981).
37. Tornqvist M, Ehrenberg L. On cancer risk estimation of urban air pollution. Environ Health Perspect 102(suppl 4):173-182 (1994).
38. Russo J, Wilgus G, Tait L, Russo IH. Influence of age and parity on the susceptibility of rat mammary gland epithelial cells in primary cultures to 7,12-dimethylbenz(a)anthracene. In Vitro 17:877-884 (1981).
39. Russo IH, Medado J, Russo J. Endocrine influences on mammary structure and development. In: Integument and mammary gland of laboratory animals (Jones TC, Mohr U, Hunt RD, eds). Berlin:Springer Verlag, 1989;252-266.
40. Russo IH, Tewari M, Russo J. Morphology and development of rat mammary gland. In: Integument and mammary gland of laboratory animals (Jones TC, Mohr U, Hunt RD, eds). Berlin:Springer-Verlag, 1989;233-252.
41. Russo J, Russo IH. Toward a physiological approach to breast cancer prevention. Cancer Epidemiol Biomarkers Prev 3:353-364 (1994).
42. Daniel CW, Silberstein GB. Postnatal development of the rodent mammary gland. In: The mammary gland (Neville MC, Daniel CW, eds). New York:Plenum Press, 1987;3-36.
43. Meyer F, Brisson J, Morrison AS, Brown JB. Endogenous sex hormones, prolactin, and mammographic features of breast tissue in premenopausal women. J Natl Cancer Inst 77:617-620 (1986).
44. Sakakura T. Mammary embryogenesis. In: The mammary gland (Neville MC, Daniel CW, eds). New York:Plenum Press, 1987;37-66.
45. MacKenzie WF, Garner FM. Comparison of neoplasms in six sources of rats. J Natl Cancer Inst 50:1234-1257 (1973).
46. Solleveld HA, Haseman JK, McConnell EE. Natural history of body weight gain, survival, and neoplasia in the F344 rat. J Natl Cancer Inst 72:929-940 (1984).
47. Zwieten MJ. Normal anatomy and pathology of the rat mammary gland. In: The rat as animal model in breast cancer research. Boston:Martinus Nijhoff, 1984;53-134.
48. Pike MC, Spicer DV, Dahmoush L, Press MF. Estrogens, progestogens, normal breast cell proliferation, and breast cancer. Epidemiol Rev 15:17-35 (1993).
49. Selman PJ, Mol JA, Rutterman GR, Garderen EV, Rijnberk A. Progestin-induced growth hormone excess in the dog originates in the mammary gland. Endocrinology 134:287-292 (1994).
50. Stolwijk JAM, Minke JMHM, Rutteman GR, Hoekstra J, Prop FJA, Misdorp W. Feline mammary carcinomas as a model for human breast cancer. II. Comparison of in vivo and in vitro adriamycin sensitivity. Anticancer Res 9:1045-1048 (1989).
51. Broerse JJ, van Bekkum DW, Zoetelief J, Zurcher C. Relative biological effectiveness for neutron carcinogenesis in monkeys and rats. Radiat Res S128-S135 (1991).
52. Dao TL. The role of ovarian hormones initiating the induction of mammary cancer in rats by polynuclear hydrocarbons. Cancer Res 22:973-980 (1962).
53. Hummel KP, Richardson FL, Feketo E. Anatomy. In: Biology of the laboratory mouse (Green EL, ed). New York:McGraw Hill Book Company, 1966;247-307.
54. Russo J. Basis of cellular autonomy in susceptibility to carcinogenesis. Toxicol Pathol 11:149-163 (1983).
55. Russo IH, Russo J. From pathogenesis to hormone prevention of mammary carcinogenesis. Cancer Surv 5:649-670 (1986).
56. Russo J, Isenberg WM, Ireland M, Russo IH. Ultrastructural changes in the mammary epithelial cell population during neoplastic development induced by chemical carcinogen. Proc Electron Microsc Soc Am 34:250-251 (1976).
57. Russo IH, Ireland W, Russo J. Ultrastructural description of three different epithelial cell types in rat mammary gland. Proc Electron Microsc Soc Am 34:146-147 (1976).
58. Russo J, Wells P. Ultrastructural localization of adenosine triphosphatase activity in resting mammary gland. J Histochem Cytochem 25:135-148 (1977).
59. Williams JM, Daniel CW. Mammary ductal elongation: differentiation of myoepithelium and basal lamina during branching morphogenesis. Dev Biol 97:274-290 (1983).
60. Russo J, Russo IH. Biological and molecular bases of mammary carcinogenesis. Lab Invest 57:112-137 (1987).
61. Ghadially FN. Diagnostic electron microscopy of tumors. London:Butterworth and Company, 1985.
62. Gusterson BA, Warburton MJ, Monaghan P. Histologic/immunocytochemical markers, mammary gland, rat. In: Integument and mammary glands (Jones TC, Mohr U, Hunt RD, eds). Berlin:Springer Verlag, 1989; 266-274.
63. Warburton MJ, Mitchell D, Ormerod EJ, Rudland P. Distribution of myoepithelial cells and basement membrane proteins in die resting, pregnant, lactating, and involuting rat mammary gland. J Histochem Cytochem 30:667-676 (1982).
64. Raynaud A. Observations sur le développement normal des ebauches de la glande mammaire des foetus males et femellas de souris. Ann Endocrinol 8:349-359 (1947).
65. Raynaud A. Action des hormones sixuelles sur le developpement embryonnaire de la glande mammaire de la souris. Comptb Rend Soc Biol 225:150-152 (1947).
66. Dickson RB, Bano M, Johnson MD, Shi YE, Martinez-Lacaci I, Amundadottir LT, Ziff B, Kurebayashi J. Steroid regulation of growth factors and protooncogenes in the normal and malignant mammary gland. In: Protooncogenes and growth factors in steroid hormone induced growth and differentiation (Khan SA, Stancel GM, eds). Boca Raton, FL:CRC Press, 1994;143-174.
67. Vonderhaar BK. Regulation of development of the normal mammary gland by hormones and growth factors. In: Breast cancer: cellular and molecular biology (Lippman ME, Dickson RB, eds). Boston:Kluwer, 1988;251-294.
68. Peluso JJ. Morphologic and physiologic features of the ovary. In: Pathobiology of the aging rat (Mohr U, Dungworth DL, Capen CC, eds). Washington, DC:ILSI Press, 1992;337-349.
69. Russo IH, Russo J. Role of hCG and inhibin in breast cancer. Int J Oncol 4:297-306 (1994).
70. Woodruff TK, Mayo KE. Regulation of inhibin synthesis in the rat ovary. Annu Rev Physiol 52:807-827 (1990).
71. Yung SY. Inhibins, activins and follistatins: gonadal proteins modulating the secretion of follicle-stimulating hormone. Endocrine Rev 9:267-293 (1988).
72. Chatterton RT. Progesterone and mammary gland development. In: The sex steroids (McKerns KW, ed). New York:Appleton-Century-Crofts, 1971.
73. Dembinski TC, Shiu RPC. Growth factors in mammary gland development and function. In: The mammary gland (Neville MC, Daniel CW, eds). New York:Plenum Press, 1987;355-382.
74. Tonelli QJ, Sorof S. Expression of a phenotype of normal differentiation in cultured mammary glands is promoted by epidermal growth factor and blocked by cyclic adenine nucleotide and prostaglandins. Differentiation 20:253-259 (1981).
75. Sirbasku DA. Estrogen induction of growth factors specific for hormone-responsive mammary, pituitary, and kidney tumor cells. Proc Natl Acad Sci USA 75:3786-3790 (1978).
76. Haslam SZ. Role of sex steroid hormones in normal mammary gland function. In: The mammary gland (Neville MC, Daniel CW, eds). New York:Plenum Press, 1987:499-535.
77. Kuhn NJ. Lactogenesis: the search for trigger mechanisms in different species. In: Comparative aspects of lactation (Peaker M, ed). New York:Academic Press, 1977;165-192.
78. Nandi S. Endocrine control of mammary gland development and function in the C3H/He Crgl mouse. J Natl Cancer Inst 21:1039-1063 (1958).
79. Mizuno H, Natio M. The role of prolactin in the mammary alveolus formation. Endocrinl JPN 2:163-169 (1956).
80. Russo IH, Russo J. Hormone prevention of mammary carcinogenesis: a new approach in anticancer research. Anticancer Res 8: 1247-1264 (1988).
81. King MM, McCoy P, Russo IH. Dietary fat may influence DMBA-initiated mammary gland carcinogenesis by modification of mammary gland development. In: Current topics in nutrition and disease (Roe, Daphne A ed). New York:Alan R. Liss, 1983;61-90.
82. Arts CJ, Glovers CA, van Den Berg H, Thijssen JH. Effect of wheat bran and energy restriction on onset of puberty, cell proliferation and development of mammary tissue in female rats. Acta Endocrinol 126:451-459 (1992).
83. Wiehle RD, Wittliff JL. Alterations in sex-steroid hormone receptors during mammary gland differentiation in the rat. Comp Biochem Physiol 76BL:409-417 (1983).
84. Hwang JJ, Lee AB, Fields PA, Haab LM, Mojonnier LE, Sherwood OD. Monoclonal antibodies specific for rat relaxin. V. Passive immunization with monoclonal antibodies throughout the second half of pregnancy disrupts development of the mammary apparatus and, hence, lactational performance in rats. Endocrinology 129:3034-3042 (1991).
85. Alvarado MV, Russo J, Russo IH. Immunolocalization of inhibin in the mammary gland of rats treated with hCG. J Histochem Cytochem 41:29-34 (1993).
86. Alvarado ME, Russo J, Russo IH. Comparative study of inhibin expression in the mammary gland of pregnant and human chorionic gonadotropin (hCG) treated rats. Proc Am Assoc Cancer Res 34:1444a. (1993).
87. Jahn GA, Edery M, Belair L, Kelly PA, Dijiane J. Prolactin receptor gene expression in rat mammary gland and liver during pregnancy and lactation. Endocrinology 128:2976-2984 (1991).
88. Helminen HJ, Ericsson JLE, Orremius S. Studies on mammary gland involution. IV. Histochemical and biochemical observations on alterations in lysosomes and lysosomal enzymes. J Ultrastruct Res 25:240-252 (1968).
89. Ciocca DR, Parente A, Russo J. Endocrinologie milieu and susceptibility of the rat mammary gland to carcinogenesis. Am J Pathol 109:47-56 (1982).
90. Wise PM. The role of the hypothalamus in aging of the female reproductive system. J Steroid Biochem 27:713-719 (1987).
91. Demarest KT, Moore KE, Riegle GD. Adenohypophyseal dopamine content and prolactin secretion in the aged male and female rat. Endocrinology 116:1316-1323 (1985).
92. Peng MT, Huang HH. Aging of hypothalamic-pituitary-ovarian function in the rat. Fertil Steril 23:535-542 (1972).
93. Felicio LS, Nelson JF, Gosden RG, Finch RE. Restoration of ovulatory cycles by young ovarian graft in aging mice: potentiation by long term ovariectomy decreases with age. Proc Soc Exp Biol Med 169:348-354 (1982).
94. Peng MT, Peng YM. Changes in the uptake of irridiated estradiol in the hypothalamus and adenohypophyisis of old female rats. Fertil Steril 24:534-539 (1974).
95. Haji M, Kato K, Nawata H, Ibayashi H. Age-related changes in concentrations of cytosol receptors for sex steroid hormones in the hypothalamus and pituitary gland of rats. Brain Res 204:373-386 (1981).
96. Kanungo MS, Patnaik SK, Koul O. Decrease in 17β-estradiol receptor in brain of aging rats. Nature 253:366-367 (1975).
97. Jrang MJ, Peng MT. Cytoplasmic and nuclear binding of estradiol in the brain pituitary of old female rats. Gerontology 27:51-57 (1981).
98. Baulieu E-E, Kelly PA, eds. Hormones: from molecules to disease. New York:Chapman and Hall, 1990.
99. Brooks CM, Koizumi K. The hypothalamus and control of integrative processes. In: Medical physiology (Mountcastle VB, ed). St. Louis, MO:C.V. Mosby, 1980;1:923-947.
100. Cowie AT, Folley SJ. The role of the adrenal cortex in mammary development and its relation to the mammogenic action of the anterior pituitary. Endocrinology 40:274-285 (1947).
101. Welsch CW. Host factors affecting the growth of carcinogen-induced rat mammary carcinomas: a review and tribute to Charles Brenton Huggins. Cancer Res 45:3415-3443 (1985).
102. Stefaneanu L, Kovacs K. Changes in structure and function of the pituitary. In: Pathobiology of the aging rat, vol 2 (Mohr U, Dungworth DL, Capen CC, eds). Washington, DC:ILSI Press, 1994;174-191.
103. Vessey MP. Exogenous hormones in the etiology of cancer in women. J Roy Soc Med 77:542-549 (1984).
104. Kelly PA, Posner BI, Tsushima T, Friessen HG. Studies of insulin, growth hormone and prolactin binding: ontogenesis, effects of sex and pregnancy. Endocrinology 95:532-539 (1974).
105. Meites J. Relation of prolactin and estrogen to mammary tumorigenesis in the rat. J Natl Cancer Inst 48:1217-1224 (1972).
106. Horvadi E, Kovacs K. The adenohypophysis. In: Functional endocrine pathology, vol 1 (Kovac K, Asa SL, eds). Boston:Blackwell Scientific Publications 1991;245-281.
107. Brawer JR, Beaudet A, Desjardins GC, Schipper HM. Minireview: pathologic effect of estradiol on the hypothalamus. Biol Reprod 49:647-652 (1993).
108. Finch C, Felicio LS, Mobbs CV, Nelson JF. Ovarian and steroidal influences on neuroendocrine aging processes in female rodents. Endocr Rev 5:467-497 (1984).
109. Czernobilsky B, Czernobilsky H. The female reproductive tract. In: functional endocrine pathology, vol 2 (Kovac K, Asa SL, eds). Boston:Blackwell Scientific Publications, 1991;608-4351.
110. Kanungo MS, Patnaik SK, Koul O. Decrease in 17β-estradiol receptor in brain of aging rats. Nature 53:366-367 (1975).
111. Sherman BM, Korenman SG. Inadequate corpus luteum function: patophysiological interpretation of human breast cancer epidemiology. Cancer 33:1306-1312 (1974).
112. Wetzel LT, Luempert LC 3rd, Breckenridge CB, Tisdel MO, Stevens JT, Thakur AK, Extrom PJ, Eldridge JC. Chronic effects of atrazine on estrus and mammary tumor formation in female Sprague-Dawley and Fischer 344. J Toxicol Environ Health 43:169-182 (1994).
113. Goodman HM. Basic medical endocrinology. New York:Raven Press, 1994;271-295.
114. McConnell RF. Comparative aspects of contraceptive steroids: effects observed in rats. Toxicol Pathol 21:3294-3295 (1989).
115. Heywood R. The toxicological assessment of the safety of hormonal contraception. In: Safety requirements for contraceptive steroids (Michel F, ed). New York:Cambridge University Press, 1989;159-165.
116. Rao GN, Piegorsch WW, Haseman JK. Influence of body weight on the incidence of spontaneous tumors in rats and mice of long-term studies. Am J Clin Nutr 45:252-260 (1987).
117. Bittner JJ. The milk influence on breast tumors in mice. Science 95:462-463 (1942).
118. Lang PL. Spontaneous neoplastic lesions and selected non-neoplastic lesions in the Crl:CD BR rat. Wilmington, MA:Charles River Laboratories, 1992.
119. Haseman JF, Huff J, Boorman GA. Use of historical control data in carcinogenicity studies in rodents. Toxicol Pathol 12:126-135 (1984).
120. Ross MH, Bras G. Lasting influence of early caloric restriction on prevalence of neoplasms in the rat. J Natl Cancer Inst 47:1095-1113 (1971).
121. 1) mice. J Natl Cancer Inst 66:1175-1181 (1981).
122. Russo J, Calaf G, Sohi N, Tahin Q, Zhang PL, Alvarado ME, Estrada S, Russo IH. Critical steps in breast carcinogenesis. Ann NY Acad Sci 698:1-20 (1993).
123. Hancock SL, Tucker MA, Hoppe RT. Breast cancer after treatment of Hodgkin's disease. Ann J Natl Cancer Inst 85:25-31 (1993).
124. BEIR: Committee on the Biological Effects of Ionizing Radiations, National Research Council. Somatic effects: Cancer. In: The effects on populations of exposure to low levels of ionizing radiation. Washington, DC:National Academy of Science, 1980;135-158.
125. Land CE, Boice JD, Shore RE, Norman JE, Tokunaga M. Breast cancer risk from low-dose exposures to ionizing radiation: results of parallel analysis of three exposed populations of women. J Natl Cancer Inst 65:353-376 (1980).
126. Finerty JC, Binhammer RT, Schneider M, Cunningham AWB. Neoplasms in rats exposed to single-dose total-body X-radiation. J Natl Cancer Inst 14:149-154 (1953).
127. Bond VP, Cronkite EP, Lippincott SW, Shellabarger CJ. Studies on radiation-induced mammary gland neoplasia in the rat. III. Relation of the neoplastic response to dose of total-body radiation. Radiat Res 12:276-284 (1960).
128. Bond VP, Shellabarger CJ, Cronkite EP, Fliedner TM. Studies on radiation-induced mammary gland neoplasia in the rat. V. Induction by localized irradiation. Radiat Res 13:318-325 (1960).
129. Broerse JJ, Hennen LA, Solleveld HA. Actuarial analysis of the hazard for mammary carcinogenesis in different rat strains after X-and neutron irradiation. Leuk Res 10:749-754 (1986).
130. van Bekkum DW, Broerse JJ, Hennen LA, Solleveld HA. The gene transfer-misrepair hypothesis of radiation carcinogenesis tested for induction of mammary tumors in rats. Leuk Res 10:761-765 (1986).
131. Shellabarger CJ. Pituitary and steroid hormones in radiation-induced mammary tumors. In: Hormones and breast cancer (Pike MC, Siteri PK, Welsch CW, eds). Cold Spring Harbor NY:Cold Spring Harbor Laboratory, 1981;339-351.
132. Shellabarger CJ, Bond BP, Aponte GE, Cronkite EP. Results of fractionation and protraction of total-body radiation on rat mammary neoplasia. Cancer Res 26:509-513 (1966).
133. Zwieten JF. Effects of irradiation and hormone administration on mammary tumor incidence. In: The rat as animal model in breast cancer research. Boston;Martinus Nijhoff, 1984;29-52.
134. Solleveld HA, van Zwieten MJ, Broerse JJ, Hollander CF. Effects of X-irradiation, ovario-hysterectomy and estradiol-17β on incidence, benign/malignant ratio and multiplicity of rat mammary neoplasms - a preliminary report. Leuk Res 10:755-763 (1986).
135. Broerse JJ, Hennen LA, Klapwijk WM, Solleveld HA. Mammary carcinogenesis in different rat strains after irradiation and hormone administration. Int J Radiat Biol 51:1091-1100 (1987).
136. Segaloff A, Maxfield WS. The synergism between radiation and estrogen in the production of mammary cancer in the rat. Cancer Res 31:166-168 (1971).
137. Stone JP, Holtzman S, Shellabarger CJ. Synergistic interactions of various doses of diethylstilbestrol and X-irradiation on mammary neoplasia in female ACI rats. Cancer Res 40:3966-3972 (1980).
138. Shellabarger CJ, Stone JP, Holtzman S. Rat differences in mammary tumor induction with estrogen and neutron radiation. J Natl Cancer Inst 61:1505-1508 (1978).
139. Holtzman S, Stone JP, Shellabarger CJ. Influence of diethylstilbestrol treatment on prolactin cells of female ACI and Sprague-Dawley rats. Cancer Res 39:779-784 (1979).
140. Yokoro K, Sumi C, Ito A, Hamada K, Kanda K, Kobsayashi T. Mammary carcinogenic effect of low-dose fission radiation in Wistar/Forth rats and its dependency on prolactin. J Natl Cancer Inst 64:1459-1466 (1980).
141. Blankenstein MA, Broerse JJ, van Zwieten MJ, van der Molen HJ. Prolactin concentration in plasma and susceptibility to mammary tumors in female rats from different strains treated chronically with estradiol-17β. Breast Cancer Res Treat 4:137-141 (1984).
142. Holtzman S, Stone JP, Shellabarger CJ. Radiation-induced mammary carcinogenesis in virgin, pregnant, lactating and post-lactating rats. Cancer Res 42:50-53 (1982).
143. Miki Y, Swensen J, Shattuck-Elden D, Futreal PA, Harshman K, Tavtigian S, Liu Q, Cochran C, Bennett LM, Ding W. A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science 266:66-71 (1994).
144. MacMahon B, Cole P, Lin TM, Lowe CR, Mirra AP, Ravnihar B, Salbur EJ, Valaoras VG, Yuasa S. Age at first birth and breast cancer risk. Bull World Health Organ 43:209-221 (1970).
145. Russo J, Russo IH. Is differentiation the answer in breast cancer prevention? Int Res Commun Med Sci 10:935-945 (1982).
146. McGregor DH, Land CE, Choi K, Tokuoka S, Liu PI, Wakabayashi I, Beebe GW. Breast cancer incidence among atomic bomb survivors, Hiroshima and Nagasaki 1950-1989. J Natl Cancer Inst 59:799-811 (1977).
147. Russo J, Russo IH. Role of differentiation on transformation of human breast epithelial cells. In: Cellular molecular biology of experimental mammary cancer (Medina D, Kidwell W, Heppner G, Anderson E, eds). New York: Plenum Press, 1987;399-417.
148. Russo J, Calaf G, Russo IH. A critical approach to the malignant transformation of human breast epithelial cells. Crit Rev Oncog 4:403-417 (1993).
149. Russo J, Russo IH. Developmental pattern of the human breast and susceptibility to carcinogenesis. Eur J Cancer Prev 2:85-100 (1993).
150. Russo J, Romero AL, Russo IH. Architectural pattern of the normal and cancerous breast under the influence of parity. Cancer Epidemiol Biomarkers Prev 3:219-224 (1994).
151. Dao TL, Chan PC. Effect of duration of high fat intake on enhancement of mammary carcinogenesis in rats. J Natl Cancer Inst 71:201-208 (1983).
152. Ito N. In vivo carcinogeneisi of 4-nitroquinoline 1-oxide and related compounds. In: Carcinogenesis, vol. 6: the nitroquinolines (Sugimura T, ed). New York:Raven Press, 1981;117-153.
153. Shirai T, Fysh JM, Lee M-S, Vaught JB, King CM. Relationship of metabolic activation on N-hydroxy-N-acylarylamines to biological response in the liver and mammary gland of the female CD rat. Cancer Res 41:4346 (1981).
154. Young S, Hallowes RC. Tumours of the mammary gland. In: Pathology of rumors in laboratory animals, vol 1 (Turusov VS, ed). IARC scientific publication no. 5. Lyon:International Agency for Research on Cancer,1973;31-73.
155. Gullino PM, Pettigrew HM, Grantham FH. N-nitrosomethylurea as mammary gland carcinogen in rats. J Natl Cancer Inst 54:401-414 (1975).
156. Thompson HJ, Meeker LD. Induction of rat mammary gland carcinoma by the subcutaneous injection of 1 methyl-1-nitrosourea. Cancer Res 43:1628-1633 (1985).
157. Rogers AE, Lee SY. Chemically-induced mammary gland tumors in rats: modulation by dietary fat. In: Dietary fat and cancer (Ip C, Bin DF, Rogers AE, Mettlin C, eds). New York:Alan R. Liss, 1986;255-282.
158. Clinton SK, Imrey PB, Alster JM, Simon J, Truex CR, Visek WJ. The combined effects of dietary protein and fat on 7,12-dimethylbenz(a)anthracene-induced breast cancer in rats. J Nutr 114:1213-1218 (1984).
159. Welsch CW, DeHoog JV, O'Connor DH. Influence of caffeine consumption on carcinomatous and normal mammary gland development in mice. Cancer Res 48:2078-2082 (1988).
160. McCormick DL, Madigan MJ, Moon RC. Modulation of rat mammary carcinogenesis by indomethacin. Cancer Res 45:1803-1809 (1985).
161. Thompson HJ, Ronan A. Effect of D,L-α-difluoromethylornithine and endocrine manipulation on the induction of mammary carcinogenesis by 1-methyl-1-nitrosourea. Carcinogenesis 57:2003-2009 (1987).
162. Rose DP, Pruitt B, Stauber P, Erturk E, Bryan GT. Influence of dosage schedule on the biological characteristics of N-nitroso-N-methylurea-induced rat mammary tumors. Cancer Res 40:235-239 (1980).
163. Tay LK, Russo J. 7,12-Dimethylbenz(a)-anthracene (DMBA) induced DNA binding and repair synthesis in susceptible and nonsusceptible mammary epithelial cells in culture. J Natl Cancer Inst 67:155-161 (1981).
164. Tay LK, Russo J. Formation and removal of 7,12-dimethylbenz(a)anthracene nucleic acid adducts in rat mammary epithelial cells with different susceptibility to carcinogenesis. Carcinogenesis 2:1327-1333 (1981).
165. Tay LK, Russo J. Effect of human chorionic gonadotropin on 7,12-dimethylbenz(a)anthracene-induced DNA binding and repair synthesis by rat mammary epithelial cells. Chem Biol Interact 55:13-21 (1985).
166. Chan PC, Dao TL. Effects of dietary fat on age-dependent sensitivity to mammary carcinogenesis. Cancer Lett 18:245-253 (1983).
167. Russo J, Tay LK, Ciocca D, Russo IH. Molecular and cellular basis of the mammary gland susceptibility to carcinogenesis. Environ Health Perspect 49:185-199 (1983).
168. Russo J, Tait L, Russo IH. Susceptibility of the mammary gland to carcinogenesis III. The cell of origin of mammary carcinoma. Am J Pathol 113:50-66 (1983).
169. Russo J, Russo IH. Boundaries in mammary carcinogenesis. In: Boundaries between promotion and progression during carcinogenesis. (Sudilovsky O, ed). New York:Plenum Press, 1991;43-59.
170. Hashimoto K, Tarnowski WM, Lever WF. Reifung und degranulierum der Matzellen in der merch. Liehen Haut Hautarzt 18:318-324 (1967).
171. Folkman J. How is blood vessel growth regulated in normal and neoplastic tissue? Cancer Res 46:467-473 (1986).
172. Dvorak HF, Dvorak AM. Basophils, mast cells and cellular immunity in animals and man. Human Pathol 3:454-456 (1972).
173. Moller L, Schuetzle D, Autrup H. Future research needs associated with the assessment of potential human health risks from exposure to toxic ambient air pollutants. Environ Health Perspect 102(suppl 4):193-210 (1994).
174. Isaacs JT. Genetic control of resistance to chemically induced mammary adenocarcinogenesis in the rat. Cancer Res 46:3958-3963 (1986).
175. Isaacs JT. Inheritance of a genetic factor from the Copenhagen rat and the suppression of chemically induced mammary adenocarcinogenesis. Cancer Res 48:2204-2213 (1988).
176. Rothschild TC, Boylan ES, Calhoon RE, Vonderhaar BK. Transplacental effects of diethylstilbestrol on mammary development and tumorigenesis in female ACI rats. Cancer Res 47:4508-4516 (1987).
177. Stone JP, Holtzman S, Shellabarger CJ. Neoplastic responses and correlated plasma prolactin levels in diethylstilbestrol-treated ACI and Sprague-Dawley rats. Cancer Res 39:773-778 (1979).
178. Aylsworth CF, Cullum ME, Zile, MH, Welsch CW. Influence of dietary retinyl acetate on normal rat mammary gland development and on the enhancement of 7,12-dimethylbenzanthracene induced rat mammary tumorigenesis by high levels of dietary fat. J Natl Cancer Inst 76:339-345 (1986).
179. Rogers AE, Conner B, Boulanger C, Lee S. Mammary tumorigenesis in rats fed diets high in lard. Lipids 21:275-284 (1986).
180. Klurfeld DM, Weber MM, Kirtchevsky D. Inhibition of chemically induced mammary and colon tumor promotion by caloric restriction in rats fed increased dietary fat. Cancer Res 47:2759-2765 (1987).
181. Kritchevsky D, Weber MM, Klurfeld DM. Dietary fat versus caloric content initiation and promotion of 7,12-dimethylbenz(a)-anthracene-induced mammary tumorigenesis in rats. Cancer Res 44:3174-3177 (1984).
182. Beth M, Berger MR, Aksoy M, Schmahl D. Comparison between the effects of dietary fat level and of calorie intake on methylnitrosurea-induced mammary carcinogenesis in female SD rats. Int J Cancer 39:737-744 (1987).
183. Cohen LA, Thompson DO, Maeura Y, Choi K, Blank ME, Rose DP. Dietary fat and mammary cancer. Promoting effects of different dietary fat on N-nitrosomethylurea-induced rat mammary tumorigenesis. J Natl Cancer Inst 77:33-42 (1986).
184. Rogers AE, Conner BH, Boulanger C, Lee SY, Carr FA, Dumouchel WH. Enhancement of 7,12-dimethylbenz(a)anthracene mammary carcinogenesis by a high lard diet. In: Dietary fiber (Vahouny GV, Kritchevsky D, eds). Plenum Publishing, 1985;449-460.
185. Sylvester PW, Russell M, Ip MM, Ip C. Comparative effects on different animal and vegetable fats fed before and during carcinogen administration on mammary tumorigenesis, sexual maturation, and endocrine function in rats. Cancer Res 46:757-762 (1986).
186. Sylvester PW, Ip C, Ip M. Effects of high dietary fat on the growth and development of ovarian-independent carcinogen-induced mammary tumors in rats. Cancer Res 46:763-769 (1986).
187. Wetsel WC, Rogers AE, Newberne PM. Dietary fat and DMBA mammary carcinogenesis in rats. Cancer Detect Prev 4:535-547 (1981).
188. Lee SY, Walsh CT, Ng SF, Rogers AE. Toxicokinetics of 7,12-dimethylbenz(a)anthracene (DMBA) in rats fed high lard or control diets. J Nutr Growth Cancer 3:167-173 (1986).
189. Wetsel WC, Rutledge A, Rogers AE. Absence of an effect of dietary corn oil content on plasma prolactin, progesterone and 17β-estradiol in female Sprague-Dawley rats. Cancer Res 44:1420-1425 (1983).
190. Lee SY, Ng SF, Busby WF, Rogers AE. Mammary gland DNA synthesis in rats fed hog lard or control diets. J Nutr Growth Cancer 4:167-174 (1987).
191. Kort WJ, Weijma IM, Bijma AM, van Schalkwijk WP, Vergroesen AJ, Westbroek DL. Omega-3 fatty acids inhibiting the growth of a transplantable rat mammary adenocarcinoma. J Natl Cancer Inst 79:593-599 (1987).
192. Welsch CW, DeHoog JV, O'Connor DH. Influence of caffeine and/or coffee consumption on the initiation and promotion phases of 7,12-dimethylbenz(a)anthracene-induced rat mammary gland tumorigenesis. Cancer Res 48:2068-2073 (1988).
193. Welsch CW, DeHoog JV. Influence of caffeine consumption on 7,12-dimethylbenz(a)-anthracene-induced mammary gland tumorigenesis in female rats fed a chemically defined diet containing standard and high levels of unsaturated fat. Cancer Res 48:2074-2077 (1988).
194. Gapstur SM, Potter SD, Sellers TA, Folsom AR. Increased risk of breast cancer with alcohol consumption in postmenopausal women. Am J Epidemiol 136:1221-1231 (1992).
195. Rogers AE, Longnecker MP. Dietary and nutritional influences on cancer: a review on epidemiologic and experimental data. Lab Invest 59:729-759 (1988).
196. Meites J. Farm animals: hormonal inductions of lactation and galactopoiesis. In: Milk: the mammary gland and its secretions (Kon SK, Cowie AT, eds). New York:Academic Press, 1961;321-367.
197. Leclercq G, Heuson JC. Physiological and pharmacological effects of estrogens in breast cancer. Biochem Biophys Acta 560:427-455 (1979).
198. Geschickter CF. The mechanism of tumor formation. In: Diseases of the breast. Philadelphia, PA:J.B. Lippincott, 1945;774-799.
199. Meites J. Relation of prolactin and estrogen to mammary tumorigenesis in the rat. J Natl Cancer Inst 48:1217-1223 (1972).
200. Stouffer RL. Corpus luteum function and dysfunction. Clin Obstet Gynecol 33:668-689 (1990).
201. Jabara AG. Effects of progesterone on 9,12-dimethyl-1,2-benzanthracene-induced mammary tumors in Sprague-Dawley rats. Br J Cancer 21:418-429 (1967).
202. Jabara AG, Harcourt AG. The effects of progesterone and ovariectomy on mammary tumors induced by 7,12-dimethylbenzathracene in Sprague-Dawley rats. Pathology 2:115-123 (1970).
203. Jabara AG, Harcourt AG Effect of progesterone, ovariectomy and adrenalectomy on mammary tumors induced by 7,12-dimethylbenzathracene in Sprague-Dawley rats. Pathology 3:209-214 (1971).
204. Jabara AG, Toyne PH, Harcourt AG. Effects of time and duration of progesterone administration on mammary tumors induced by 7,12-dimethylbenzathracene in Sprague-Dawley rats. Br J Cancer 27:63-71 (1973).
205. Shay H, Harri C, Gruenstein M. Influence of sex hormones on the incidence and form of tumors produced in male or female rats by gastric instillation of methylcholanthrene. J Natl Cancer Inst 13:307-332 (1952).
206. Matzuk MM, Finegold MJ, Su JGJ, Husueh AJW, Bradley A. Alpha inhibin is a tumor suppressor gene with gonadal specificity in mice. Nature 360:313-319 (1992).
207. Manni A, Trujillo JE, Pearson OH. Predominant role of prolactin in stimulating the growth of 7,12-dimethylbenz(a)-anthracene-induced rat mammary tumors. Cancer Res 37:1216-1219 (1977).
208. Nagasawa H. Prolactin: its role in the development of mammary tumors. Med Hypotheses 5:1117-1121 (1979).
209. Nagasawa H, Morii S. Prophylaxis of spontaneous mammary tumorigenesis by temporal inhibition of prolactin secretion in rats at young ages. Cancer Res 41:1935-1937 (1981).
210. Welsch CW. Prolactin and the development and progression of early neoplastic mammary gland lesions. Cancer Res 38:4054-4058 (1978).
211. Welsch CW, Brown CK, Goodrich-Smith M, Van J, Denenberg B, Anderson T, Brooks CL. Inhibition of mammary tumorigenesis in carcinogen-treated Lewis rats by suppression of prolactin secretion. J Natl Cancer Inst 63:1211-1214 (1979).
212. Swanson SM, Guzman RC, Christov K, Miyamoto S, Nandi S. Pituitary-isografted mice are highly susceptible to MNU-induced mammary carcinogenesis irrespective of the level of alveolar differentiation. Carcinogenesis 15:1341-1346 (1994).
213. Welsch CW, Nagasawa H. Prolactin and murine mammary tumorigenesis: a review. Cancer Res 37:951-963 (1977).
214. Formelli F, Zaccheo T, DiSalle E, Ornati G, DiMarco A. Correlation between inhibitor effects on prolactin secretion and antitumor activity of new ergoline compounds on DMBA-induced tumors in rats. Eur J Cancer Clin Oncol 19:1545-1551 (1983).
215. Kamberi IA, Mical RS, Potter JC. Effect of anterior pituitary perfusion and intraventricular injection of catacholamines and indoleamines on LH release. Endocrinology 87:1-12 (1970).
216. Sow AM, Sonnenschein C. Estrogen receptor levels in estrogen sensitive cells in culture. J Steroid Biochem 11:1185-1190 (1979).
217. Brawer JR, Sonnenschein C. Cytopathological effects of estradiol on the accurate nucleus of the female rat. A possible mechanism for pituitary tumorigenesis. Am J Anat 144:57-88 (1975).
218. Berkvens JM, van Nesselrovy JHJ, Kroes R. Spontaneous tumors in the pituitary gland of old Wistar rats. A morphological and immunocytochemical study. J Pathol 130:179-191(1980).
219. MacLeod RM. Regulation of prolactin secretion. In: Frontiers in neuroendocrinology, (Martini L, Ganong WF, eds). New York: Raven Press, 1976;164-194.
220. Yen SSC. Clinical endocrinology of reproduction. In: Hormones: from molecules to disease (Baulieu E-E, Kelly PA, eds). New York: Chapman and Hall, 1990;445-482.
221. Russo IH, Koszalka MS, Russo J. Protective effect of chorionic gonadotropin on DMBA-induced mammary carcinogenesis. Br J Cancer 62:243-247 (1990).
222. Nisula BC, Taliadouros GS, Carayon P. Primary and secondary biologic activities intrinsic to the human chorionic gonadotropin molecule. In: Chorionic gonadotropin (Segal SJ, ed). NewYork:Plenum Press, 1980;17-35.
223. Wide L, Hobson B, Wide M. Chorionic gonadotropin in rodents. In: Chorionic gonadotropin (Segal SJ, ed). New York:Plenum Press, 1980;37-51.
224. Russo IH, Koszalka M, Russo J. Human chorionic gonadotropin and mammary cancer prevention. J Natl Cancer Inst 82:1286-1289 (1990).
225. Russo IH, Koszalka M, Russo J. Effect of human chorionic gonadotropin on mammary gland differentiation and carcinogenesis. Carcinogenesis 11:1849-1855 (1990).
226. Russo IH, Russo J. Physiological basis of breast cancer prevention. Eur J Cancer Prev 2:101-111 (1993).
227. Faulkner A, Peaker M. Regulation of mammary glucose metabolism in lactation. In: The mammary gland: development, regulation and function. (Neville MC, Daniel CW, eds). New York:Plenum Press, 1987;535-562.
228. Topper JY, Nicholas KR, Sankaran L, Kulski J. Insulin as a developmental hormone. In: Hormones and cancer (Gurpide E, Calandra R, Levy C, Soto RJ, eds). New York:Alan R. Liss, 1984;63-77.
229. Heuson JC, Legros N. Study of the growth-promoting effect of insulin in relation to carbohydrate metabolism in organ culture of rat mammary carcinoma. Eur J Cancer 4:1-7 (1968).
230. Heuson JC, Legros N. Effect of insulin and of alloxan diabetes on growth of the rat mammary carcinoma in vivo. Eur J Cancer 6:349-351 (1970).
231. Heuson JC, Legros N. Influence of insulin deprivation on growth of the 7,12-dimethylbenzanthracene-induced mammary carcinoma in rats subjected to alloxan diabetes and food restriction. Cancer Res 32:226-232 (1972).
232. Heuson NC, Legro N, Heimann R. Influence of insulin administration on growth of the 7,12-dimethylbenzathracene-induced mammary carcinoma in intact, oophorectomized, and hypophysectomized rats. Cancer Res 32:233-238 (1972).
233. Hilf R, Hissin PJ, Shafie SM. Regulatory interrelationships for insulin and estrogen action in mammary tumors. Cancer Res 38:4076-4085 (1978).
234. Milgrom E. Steroid Hormones. In: Hormones: from molecules to disease (Baulieu E-E, Kelly PA, eds). Paris:Hermann Publishers in arts and sciences (published simulteneously in Britain; London:Chapman and Hall) 1990;387-437.
235. Rommerts FFG. Testosterone: an overview of biosynthesis, transport, metabolism and action. In: Testosterone - action, deficiency, substitution (Nieschlag E, Behre HM, eds). Berlin: Springer-Verlag, 1990;1-22.
236. Rochefort H. Biochemical basis of breast cancer treatment by androgens and progestins. In: Hormones and cancer (Gurpide E, Calandra R, Levy C, Soto RJ, eds). New York:Alan R. Liss, 1984;79-95.
237. Ercoli A, Briziarelli G. Effect of enrol-ether derivatives of dihydrotestosterone on 3-methylcholanthrene-induced rat mammary carcinoma. J Natl Cancer Inst 27:1173-1187 (1961).
238. Griswold DP, Green CH. Observations on the hormone sensitivity of 7,12-dimethylbenzanthracene-induced mammary tumors in the Sprague-Dawley rat. Cancer Res 30:819-826 (1970).
239. Harada T, Rooks WH, Dorfman RI. An inhibitory effect of steroids on 20-methylcholanthrene and 7,12-dimethylbenzanthracene-induced rat mammary tumors. Oncologia 19:3-10 (1965).
240. Heise E, Gorlich M. Growth and therapy of mammary tumors induced by 7,12-dimethylbenzaanthracene in rats. Br J Cancer 20:539-545 (1966).
241. Quadri SK, Kledzik GS, Meites J. Counteraction by prolactin androgen-induced inhibition of mammary tumor growth in rats. J Natl Cancer Inst 52:875-878 (1974).
242. Shafie SM. Estrogen and the growth of breast cancer: new evidence suggests indirect action. Science 209:701-702 (1980).
243. Lissitzky S, Thyroid hormones. In: Hormones: from molecules to disease (Baulieu E-E, Kelly, PA, eds). Paris:Hermann Publishers in arts and sciences (published simulteneously in Britain; London:Chapman and Hall) 1990;343-386.
244. Vonderhaar BK. Hormones and growth factors in mammary gland development. In: Control of cell growth and proliferation (Venezial CM, ed), New York:Van Nostrand and Reinhold, 1984;11-33.
245. Vonderhaar BK. Prolactin: transport, function, and receptors in mammary gland development and differentiation. In: The mammary gland: development, regulation and function (Neville MC, Daniel CW, eds). New York: Plenum Press, 1987;383-438.
246. Vonderhaar BK, Greco AE. Effect of thyroid status on development of spontaneous mammary tumors in primiparous C3H mice. Cancer Res 42:4553-4561 (1982).
247. Vonderhaar BK. Effect of thyroid hormones on mammary tumor induction and growth. In: Hormonal regulation of experimental mammary tumors (Leung BS, ed). Elmsford, NY:Pergamon Press, 1982;138-154.
248. Morabia A, Szklo M, Stewart W, Schuman L, Thomas DB, Zacur HA. Thyroid hormones and duration of ovulatory activity in the etiology of breast cancer. Cancer Epidemiol Biomarkers Prev 1:389-393 (1992).
249. Brinton LA, Hoffman. DA, Hoover R, Fraumeni JF Jr. Relationship of thyroid disease and use of thyroid supplements to breast cancer risk. J Chronic Dis 37:877-893 (1984).
250. Goldman MB, Monson RR, Maloof F. Cancer mortality in women with thyroid disease. Cancer Res 50:2283-2289 (1990).
251. Russo J, Rivera R, Russo IH. Influence of age and parity on the development of the human breast. Breast Cancer Res Treat 23:211-218 (1992).
252. De Waard F, Trichopoulos D. A unifying concept of the aetiology of breast cancer. Int J Cancer 41:666-669 (1988).
253. John EM, Kelsey JL. Radiation and other environmental exposures and breast cancer. Epidemiol Rev 15:157-162 (1993).
254. Wellings SR, Jensen HM, Marcum RG. An atlas of subgross pathology of 16 human breasts with special reference to possible precancerous lesions. J Natl Cancer Inst 55:231-275 (1975).
255. Russo J, Reina D, Frederick J, Russo IH. Expression of phenotypical changes by human breast epithelial cells treated with carcinogens in vitro. Cancer Res 48:2837-2857 (1988).
256. Russo J, Mills MJ, Moussalli MJ, Russo IH. Influence of breast development and growth properties in vitro. In Vitro Cell Dev Biol 25:643-649 (1989).
257. Anwar WA. Monitoring of human populations at risk by different cytogenetic end points. Environ Health Perspect 102(suppl 4):131-134 (1994).
258. Connolly RB, Andersen ME. Biologically-based pharmacodynamic models: tools for toxicological research and risk assessment. Ann Rev Pharmacol Toxicol 31:503-523 (1991).
259. Crump KS. Risk assessment for benzene induced leukemia. In: Oncogene and transgenics correlates of cancer risk assessment (Zervos C, ed). New York:Plenum Press, 1992;241-262.
260. Moltholt B. A threshold for benzene leukemogenesis. In: Oncogene and transgenics correlates of cancer risk assessment (Zervos C, ed). New York:Plenum Press, 1992;305-312.
261. Kokoska SM. The analysis of cancer chemoprevention experiments. Biometrics 43:525-534 (1987).
262. Paynter OE, Burin GJ, Jaeger RB, Gregorio CA. Goitrogens and thyroid follicular cell neoplasia. Evidence for a threshold process. Regul Toxicol Pharmacol 8:102-119 (1988).
263. Ashby J, Tennant RW. Prediction of rodent carcinogenicity for 44 chemicals:results. Mutagenesis 9:7-15 (1994).
264. Barren JC. Mechanisms of multistep carcinogenesis and carcinogen risk assessment. Environ Health Perspect 100:9-20 (1993).
265. Lang L. Mouse or molecule? Mechanism-based toxicology in cancer risk assessment. Environ Health Perspect 103:334-336 (1995).
266. Sutter TR. Molecular and cellular approaches to extrapolation for risk assessment. Environ Health Perspect 103:386-389 (1995).